The influence of drug class on reward in substance use disorders
Pharmacology Biochemistry and Behavior · 2024-07 · 240 · 173771
DOI: 10.1016/j.pbb.2024.173771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacology Biochemistry and Behavior, 2024-07. Verfasst von Jermaine D Jones und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division on Substance Use Disorders, Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, 1051 Riverside Drive, …. Hauptthemen laut MEDLINE: Reward, Substance-Related Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
In the United States, the societal costs associated with drug use surpass $500 billion annually. The rewarding and reinforcing properties that drive the use of these addictive substances are typically examined concerning the neurobiological effects responsible for their abuse potential. In this review, terms such as "abuse potential," "drug," and "addictive properties" are used due to their relevance to the methodological, theoretical, and conceptual framework for understanding the phenomenon of drug-taking behavior and the associated body of preclinical and clinical literature. The use of these terms is not intended to cast aspersions on individuals with substance use disorders (SUD). Understanding what motivates substance use has been a focus of SUD research for decades. Much of this corpus of work has focused on the shared effects of each drug class to increase dopaminergic transmission within the central reward pathways of the brain, or the "reward center." However, the precise influence of each drug class on dopamine signaling, and the extent thereof, differs considerably. Furthermore, the aforementioned substances have effects on several neurobiological targets that mediate and modulate their addictive properties. The current manuscript sought to review the influence of drug class on the rewarding effects of each of the major pharmacological classes of addictive drugs (i.e., psychostimulants, opioids, nicotine, alcohol, and cannabinoids). Our review suggests that even subtle differences in drug effects can result in significant variability in the subjective experience of the drug, altering rewarding and other reinforcing effects. Additionally, this review will argue that reward (i.e., the attractive and motivational property of a stimulus) alone is not sufficient to explain the abuse liability of these substances. Instead, abuse potential is best examined as a function of both positive and negative reinforcing drug effects (i.e., stimuli that the subject will work to attain and stimuli that the subject will work to end or avoid, respectively). Though reward is central to drug use, the factors that motivate and maintain drug taking are varied and complex, with much to be elucidated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division on Substance Use Disorders, Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address: Jermaine.Jones@nyspi.colu…
- Division on Substance Use Disorders, Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, USA.
- CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031, USA.
- Department of Psychiatry, The University of British Columbia, 430-5950 University Blvd., Vancouver V6T 1Z3, BC, Canada.
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Jones, J. D., Arout, C. A., Luba, R., Murugesan, D., Madera, G., Gorsuch, L., Schusterman, R., & Martinez, S. (2024). The influence of drug class on reward in substance use disorders. Pharmacology Biochemistry and Behavior, 240, 173771. https://doi.org/10.1016/j.pbb.2024.173771
Vancouver
Jones JD, Arout CA, Luba R, Murugesan D, Madera G, Gorsuch L, et al. The influence of drug class on reward in substance use disorders. Pharmacology Biochemistry and Behavior. 2024;240:173771. doi:10.1016/j.pbb.2024.173771
BibTeX
@article{Jones2024,
author = {Jones, Jermaine D and Arout, Caroline A and Luba, Rachel and Murugesan, Dillon and Madera, Gabriela and Gorsuch, Liam and Schusterman, Rebecca and Martinez, Suky},
title = {The influence of drug class on reward in substance use disorders},
journal = {Pharmacology Biochemistry and Behavior},
year = {2024},
volume = {240},
pages = {173771},
doi = {10.1016/j.pbb.2024.173771}
}
EUVIMED